NCT01990937

Oral Midazolam for Sedation in Esophagogastroduodenoscopy(EGD)

Effectiveness of Oral Midazolam for Sedation in Patients Undergoing Upper Gastrointestinal Endoscopy

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 260 (estimated)
• Sponsor: Phramongkutklao College of Medicine and Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Can oral midazolam used for sedation in patients undergoing upper gastrointestinal endoscopy ?

Detailed description

Five mg of midazolam was intake orally about 30 minutes before undergoing perform upper gastrointestinal endoscopy. Declined of anxiety scores was primary end point.

Conditions

• Conscious Sedation Failure During Procedure

Interventions

Type	Name	Description
DRUG	Oral midazolam	5 mg in 15 mL of apple juice, orally 30 minutes before undergoing EGD

Timeline

• Start date: 2013-10-01
• Primary completion: 2014-12-01
• Completion: 2015-02-01
• First posted: 2013-11-25
• Last updated: 2014-10-29

Locations

1 site across 1 country: Thailand